Research Acknowledgment & Age Verification
Access to our peptide portfolio is reserved for individuals of legal age acquiring products for laboratory research.
BPC-157 + TB-500 supplies a co-lyophilized dual-peptide formulation engineered at a verified 1:1 stoichiometric ratio, pairing the cytoprotective signaling fragment BPC-157 (15-AA) with the actin-sequestering peptide TB-500 (43-AA). This dual-matrix complex is evaluated in multi-pathway laboratory assays examining collaborative endothelial migration, focal adhesion signaling, and extracellular architecture dynamics. Co-lyophilized under sterile nitrogen to ensure stoichiometric stability between components. Supplied strictly for laboratory research. Not for human or veterinary use.
Chemical & Analytical Specifications
Laboratory Handling & Solvent Protocols
To preserve structural integrity and peptide purity, lyophilized materials should be maintained at -20°C in an airtight container protected from ambient moisture and light. Reconstitution should be conducted under sterile conditions using bacteriostatic water (0.9% benzyl alcohol) or sterile laboratory saline. Allow the diluent to run gently down the interior vial wall; avoid vigorous shaking or vortexing to prevent shear-induced degradation. Reconstituted aliquots must be stored at 2°C to 8°C and evaluated within 28 to 30 days.
BPC-157 + TB-500 Synergistic Blend
Research Pathways & Profile
Analytical Specifications & Sequence
Handling, Solvent & Storage Guidelines
1All peptide compounds cataloged are intended exclusively for laboratory research, biochemical assays, and analytical characterization. Strictly not for human, veterinary, diagnostic, or therapeutic administration.
2Analytical purity (≥99%) is validated via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). Compound integrity is dependent on adherence to cold-chain storage and inert handling protocols.
3The acquiring entity assumes sole responsibility for regulatory compliance, laboratory safety protocols, and safe handling in accordance with federal, state, and local standards. èvelan expressly disclaims liability for off-label or unapproved application.
View Full Legal & Research Disclaimer →



